Product Information

OLMESARTAN MEDOXOMIL 40 MG TAB is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1083 per EA under NDC 64980060303. Its NADAC has been published 107 times since Aug 7, 2024.

FDA first approved this application on May 18, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OLMESARTAN MEDOXOMIL 40 MG TAB

olmesartan medoxomil
$0.1083per EA

Strength

40 mg/1

NDC

64980060303

Classification

Generic

Dosage Form

TABLET, COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

OLMESARTAN MEDOXOMIL

Approval Type

Generic (ANDA)

FDA Application

ANDA208659

FDA Approved

5/18/2020

TE Code

AB

On Market Since

3/30/2024

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker

Price Statistics

The NADAC for OLMESARTAN MEDOXOMIL 40 MG TAB has been published 107 times since Aug 7, 2024, and over the history we have for it it has declined 8.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1083 per EA
All-time high$0.1340 (Oct 16, 2024)
All-time low$0.1083 (Aug 19, 2026)
52-week high$0.1235
52-week low$0.1083
Median price$0.1224
Average price$0.1211
Largest weekly change-13.7% (Nov 20, 2024)
Weeks tracked107
Tracking sinceAug 7, 2024

Price History

1W

-1.0%

1M

-1.0%

3M

-5.3%

6M

-12.3%

1Y

-11.5%

3Y

N/A

5Y

N/A

All

-8.3%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of OLMESARTAN MEDOXOMIL 40 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for OLMESARTAN MEDOXOMIL 40 MG TAB, manufactured by Rising Pharma Holdings Inc., is $0.1083 per EA (NDC 64980060303), effective Aug 19, 2026.

How has the price of OLMESARTAN MEDOXOMIL 40 MG TAB changed over time?

Over the history we have for it, the NADAC for OLMESARTAN MEDOXOMIL 40 MG TAB has declined 8.3%. It has been tracked across 107 weekly CMS publications since Aug 7, 2024.

What are the highest and lowest recorded NADAC prices for OLMESARTAN MEDOXOMIL 40 MG TAB?

Since Aug 7, 2024, the NADAC for OLMESARTAN MEDOXOMIL 40 MG TAB has ranged from a low of $0.1083 (Aug 19, 2026) to a high of $0.1340 (Oct 16, 2024), with a median of $0.1224 per EA.

Are there cheaper alternatives to OLMESARTAN MEDOXOMIL 40 MG TAB?

7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OLMESARTAN MEDOXOMIL 40 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures OLMESARTAN MEDOXOMIL 40 MG TAB?

OLMESARTAN MEDOXOMIL 40 MG TAB (NDC 64980060303) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.